Atlas Trials

PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD

Clinical trial NCT01566773 · COMPLETED

Trial details

NCT number
NCT01566773
Sponsor
Pearl Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2012-03-01
Primary completion
2012-08-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.